Benitec Biopharma Overview
- Year Founded
-
1995
- Status
-
Public
- Employees
-
24
- Stock Symbol
-
BNTC
- Investments
-
1
- Share Price
-
$9.00
- (As of Friday Closing)
Benitec Biopharma General Information
Description
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on advancing novel genetic medicines. Its technology could provide a one-shot cure for a wide range of diseases that require strict, ongoing treatment regimens or have no effective treatment or only palliative care options. The Company is developing a silence-and-replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life-threatening genetic disorder. The company has a single operating segment, which is the business of discovery and development of therapeutic agents for the treatment of genetic disorders.
Contact Information
Website
www.benitec.comCorporate Office
- 3940 Trust Way
- Hayward, CA 94545
- United States
Corporate Office
- 3940 Trust Way
- Hayward, CA 94545
- United States
Benitec Biopharma Timeline
Benitec Biopharma Stock Performance
As of 13-Nov-2026, Benitec Biopharma’s stock price is $9.00. Its current market cap is $315M with 34.9M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $9.00 | $9.09 | $7.88 - $14.39 | $315M | 34.9M | 177K | -$1.02 |
Benitec Biopharma Financials Summary
As of 30-Sep-2026, Benitec Biopharma has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 30-Jun-2026 | FY 2025 30-Jun-2025 | FY 2024 30-Jun-2024 |
|---|---|---|---|---|
| EV | 169,617 | 275,776 | 204,506 | 51,690 |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (55,152) | (50,634) | (40,807) | (22,312) |
| Net Income | (49,506) | (45,546) | (37,917) | (21,751) |
| Total Assets | 179,098 | 182,623 | 99,592 | 52,210 |
| Total Debt | 642 | 762 | 849 | 284 |
Benitec Biopharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Benitec Biopharma Comparisons
Industry
Financing
Details
Benitec Biopharma Competitors (29)
One of Benitec Biopharma’s 29 competitors is Arbutus Biopharma, a Corporation company based in Warminster, PA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Arbutus Biopharma | Corporation | Warminster, PA | ||||
| Cardiff Oncology | Formerly Angel backed | San Diego, CA | ||||
| BPS Bioscience | Corporation | San Diego, CA | ||||
| GeneCast Biotechnology | Private Equity-Backed | Wuxi, China | ||||
| Kite Pharma | Formerly VC-backed | Santa Monica, CA |
Benitec Biopharma Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Benitec Biopharma Patents
Benitec Biopharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-2633051-A1 | Hbv treatment | Active | 28-Oct-2010 | ||
| EP-2633051-A4 | Hbv treatment | Active | 28-Oct-2010 | ||
| EP-2633051-B1 | Hbv treatment | Inactive | 28-Oct-2010 | C12N15/1131 |
Benitec Biopharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Benitec Biopharma Acquisitions (1)
Benitec Biopharma’s most recent deal was a Merger/Acquisition with Tacere Therapeutics for . The deal was made on 30-Oct-2012.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Tacere Therapeutics | 30-Oct-2012 | Merger/Acquisition | Drug Discovery |
Benitec Biopharma ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Benitec Biopharma FAQs
-
When was Benitec Biopharma founded?
Benitec Biopharma was founded in 1995.
-
Where is Benitec Biopharma headquartered?
Benitec Biopharma is headquartered in Hayward, CA.
-
What is the size of Benitec Biopharma?
Benitec Biopharma has 24 total employees.
-
What industry is Benitec Biopharma in?
Benitec Biopharma’s primary industry is Biotechnology.
-
Is Benitec Biopharma a private or public company?
Benitec Biopharma is a Public company.
-
What is Benitec Biopharma’s stock symbol?
The ticker symbol for Benitec Biopharma is BNTC.
-
What is the current stock price of Benitec Biopharma?
As of 13-Nov-2026 the stock price of Benitec Biopharma is $9.00.
-
What is the current market cap of Benitec Biopharma?
The current market capitalization of Benitec Biopharma is $315M.
-
Who are Benitec Biopharma’s competitors?
Arbutus Biopharma, Cardiff Oncology, BPS Bioscience, GeneCast Biotechnology, and Kite Pharma are some of the 29 competitors of Benitec Biopharma.
-
What is Benitec Biopharma’s annual earnings per share (EPS)?
Benitec Biopharma’s EPS for 12 months was -$1.02.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
